Activity Impairment Assessment (AIA)

Wild DJ; Clayson DJ; Keating K; Gondek K


Basic description

Developed in 2005


Wild DJ; Clayson DJ; Keating K; Gondek K

Copyright (c) 2003, 2004 by Bayer Pharmaceutical Corporation. All rights reserved.
To assess the activity impairment associated with uncomplicated urinary tract infection
Therapeutic area
  • Bacterial Infections and Mycoses
  • Female Urogenital Diseases and Pregnancy Complications
  • Male Urogenital Diseases
Therapeutic indication

Urinary Tract Infections

Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English for the USA
1 translation(s)
Bibliographic reference(s) of the original questionnaire

Wild DJ, Clayson DJ, Keating K, Gondek K. Validation of a patient-administered questionnaire to measure the activity impairment experienced by women with uncomplicated urinary tract infection: the Activity Impairment Assessment (AIA). Health Qual Life Outcomes. 2005 Jul 15;3:42 (Full Text Article)

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us